Janssen’s company group chairman for Asia Pacific, Kris Sterkens distills the core elements of what it means to be a transformational medical innovator, while exclaiming how this characterization has molded the company’s patient-centric commitments across the region.
When several others have experienced drawback, what factors have best positioned Janssen for success in this region?
No matter which market you are in, you are starting to see an evolution of how stakeholders choose to engage with pharmaceutical companies
